Insider Transactions in Q4 2017 at Unitedhealth Group Inc (UNH)
Insider Transaction List (Q4 2017)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 22
2017
|
Stephen J Hemsley Director |
SELL
Bona fide gift
|
Direct |
46,000
-1.48%
|
-
|
Dec 22
2017
|
David S Wichmann Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
24,000
-2.98%
|
-
|
Dec 21
2017
|
David S Wichmann Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
114,255
-12.43%
|
$25,364,610
$222.38 P/Share
|
Dec 21
2017
|
David S Wichmann Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
203,642
+18.13%
|
$6,720,186
$33.94 P/Share
|
Dec 15
2017
|
Larry C Renfro Vice Chmn, UHG and CEO, Optum |
SELL
Open market or private sale
|
Direct |
22,598
-11.57%
|
$4,994,158
$221.75 P/Share
|
Dec 14
2017
|
Steven H Nelson EVP & CEO, UnitedHealthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
894
-4.55%
|
$197,574
$221.25 P/Share
|
Dec 14
2017
|
Stephen J Hemsley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
797
-0.05%
|
$176,137
$221.25 P/Share
|
Dec 14
2017
|
Larry C Renfro Vice Chmn, UHG and CEO, Optum |
SELL
Payment of exercise price or tax liability
|
Direct |
574
-0.29%
|
$126,854
$221.25 P/Share
|
Dec 14
2017
|
David S Wichmann Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,822
-0.25%
|
$402,662
$221.25 P/Share
|
Dec 12
2017
|
William C Ballard Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
75
+0.1%
|
-
|
Dec 12
2017
|
Richard T Burke Director |
BUY
Grant, award, or other acquisition
|
Direct |
75
+0.0%
|
-
|
Dec 12
2017
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
4
+0.34%
|
-
|
Dec 12
2017
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
97
+0.3%
|
-
|
Dec 12
2017
|
Rodger A Lawson Director |
BUY
Grant, award, or other acquisition
|
Direct |
70
+0.25%
|
-
|
Dec 12
2017
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.7%
|
-
|
Dec 12
2017
|
Glenn M Renwick Director |
BUY
Grant, award, or other acquisition
|
Direct |
142
+0.32%
|
-
|
Dec 12
2017
|
Kenneth Irwin Shine Director |
BUY
Grant, award, or other acquisition
|
Direct |
97
+0.34%
|
-
|
Dec 12
2017
|
Gail R Wilensky |
BUY
Grant, award, or other acquisition
|
Direct |
70
+0.12%
|
-
|
Dec 12
2017
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.7%
|
-
|
Dec 12
2017
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
447
+0.03%
|
-
|
Dec 12
2017
|
Steven H Nelson EVP & CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
65
+0.33%
|
-
|
Dec 12
2017
|
Larry C Renfro Vice Chmn, UHG and CEO, Optum |
BUY
Grant, award, or other acquisition
|
Direct |
122
+0.06%
|
-
|
Dec 12
2017
|
Thomas E Roos Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63
+0.28%
|
-
|
Dec 12
2017
|
Marianne D Short EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59
+0.07%
|
-
|
Dec 12
2017
|
David S Wichmann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
134
+0.02%
|
-
|
Dec 12
2017
|
D Ellen Wilson Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
52
+0.16%
|
-
|
Dec 12
2017
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
86
+0.14%
|
-
|
Dec 04
2017
|
Michele J Hooper Director |
SELL
Open market or private sale
|
Direct |
5,000
-13.52%
|
$1,110,000
$222.2 P/Share
|
Dec 04
2017
|
Michele J Hooper Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.91%
|
$125,000
$25.08 P/Share
|
Nov 29
2017
|
Richard T Burke Director |
SELL
Bona fide gift
|
Direct |
10,000
-0.55%
|
-
|
Nov 29
2017
|
Gail R Wilensky |
SELL
Open market or private sale
|
Direct |
5,600
-4.62%
|
$1,248,800
$223.38 P/Share
|
Nov 29
2017
|
Gail R Wilensky |
BUY
Exercise of conversion of derivative security
|
Direct |
5,600
+4.3%
|
$291,200
$52.38 P/Share
|
Nov 21
2017
|
Richard T Burke Director |
SELL
Bona fide gift
|
Direct |
10,000
-0.55%
|
-
|
Nov 14
2017
|
Kenneth Irwin Shine Director |
SELL
Open market or private sale
|
Direct |
457
-1.56%
|
$96,427
$211.03 P/Share
|
Nov 03
2017
|
Thomas E Roos Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,853
-7.52%
|
$392,836
$212.87 P/Share
|
Oct 19
2017
|
Thomas E Roos Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
975
-3.81%
|
$199,875
$205.47 P/Share
|
Oct 02
2017
|
William C Ballard Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
222
+0.31%
|
-
|
Oct 02
2017
|
Richard T Burke Director |
BUY
Grant, award, or other acquisition
|
Direct |
222
+0.01%
|
-
|
Oct 02
2017
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
380
+24.34%
|
-
|
Oct 02
2017
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
222
+0.69%
|
-
|
Oct 02
2017
|
Rodger A Lawson Director |
BUY
Grant, award, or other acquisition
|
Direct |
222
+0.8%
|
-
|
Oct 02
2017
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
140
+50.0%
|
-
|
Oct 02
2017
|
Glenn M Renwick Director |
BUY
Grant, award, or other acquisition
|
Direct |
412
+0.93%
|
-
|
Oct 02
2017
|
Kenneth Irwin Shine Director |
BUY
Grant, award, or other acquisition
|
Direct |
222
+0.75%
|
-
|
Oct 02
2017
|
Gail R Wilensky |
BUY
Grant, award, or other acquisition
|
Direct |
223
+0.2%
|
-
|
Oct 02
2017
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
140
+50.0%
|
-
|